VistaGen Therapeutics(VTGN) - 2025 Q4 - Earnings Call Transcript

VistaGen Therapeutics (VTGN) Q4 2025 Earnings Call June 17, 2025 05:00 PM ET Company Participants Mark McPartland - Senior Vice President, Investor RelationsShawn Singh - President, Chief Executive Officer and DirectorCindy Anderson - CFOAndrew Tsai - SVP Conference Call Participants None - AnalystMyles Minter - Research Analyst - Healthcare Operator Good day everyone and thank you for standing by. Welcome to the Vistagen Therapeutics Fiscal Year End twenty twenty five Corporate Update Conference Call and W ...